nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Clenbuterol—TNF—liver cancer	0.00735	0.391	CrCbGaD
Salbutamol—Clenbuterol—CYP1A1—liver cancer	0.00559	0.297	CrCbGaD
Salbutamol—Eructation—Epirubicin—liver cancer	0.00344	0.0035	CcSEcCtD
Salbutamol—Anaphylactic shock—Sorafenib—liver cancer	0.00338	0.00344	CcSEcCtD
Salbutamol—Infection—Sorafenib—liver cancer	0.00336	0.00342	CcSEcCtD
Salbutamol—Inflammation—Doxorubicin—liver cancer	0.00334	0.0034	CcSEcCtD
Salbutamol—Shock—Sorafenib—liver cancer	0.00332	0.00339	CcSEcCtD
Salbutamol—Nervous system disorder—Sorafenib—liver cancer	0.00331	0.00338	CcSEcCtD
Salbutamol—Skin disorder—Sorafenib—liver cancer	0.00328	0.00334	CcSEcCtD
Salbutamol—Musculoskeletal pain—Doxorubicin—liver cancer	0.00328	0.00334	CcSEcCtD
Salbutamol—Anorexia—Sorafenib—liver cancer	0.00322	0.00328	CcSEcCtD
Salbutamol—Cramps of lower extremities—Epirubicin—liver cancer	0.00321	0.00328	CcSEcCtD
Salbutamol—Eructation—Doxorubicin—liver cancer	0.00318	0.00324	CcSEcCtD
Salbutamol—Pulmonary oedema—Epirubicin—liver cancer	0.00311	0.00317	CcSEcCtD
Salbutamol—Epinephrine—TNF—liver cancer	0.00309	0.164	CrCbGaD
Salbutamol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00308	0.00314	CcSEcCtD
Salbutamol—Hypertonia—Epirubicin—liver cancer	0.00307	0.00313	CcSEcCtD
Salbutamol—Mental disability—Epirubicin—liver cancer	0.00304	0.00309	CcSEcCtD
Salbutamol—Dyspnoea—Sorafenib—liver cancer	0.00301	0.00307	CcSEcCtD
Salbutamol—Lymphadenopathy—Epirubicin—liver cancer	0.00298	0.00303	CcSEcCtD
Salbutamol—Cramps of lower extremities—Doxorubicin—liver cancer	0.00297	0.00303	CcSEcCtD
Salbutamol—Dyspepsia—Sorafenib—liver cancer	0.00297	0.00303	CcSEcCtD
Salbutamol—Decreased appetite—Sorafenib—liver cancer	0.00294	0.00299	CcSEcCtD
Salbutamol—Diabetes mellitus—Epirubicin—liver cancer	0.00292	0.00298	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Sorafenib—liver cancer	0.00292	0.00297	CcSEcCtD
Salbutamol—Fatigue—Sorafenib—liver cancer	0.00291	0.00297	CcSEcCtD
Salbutamol—Pain—Sorafenib—liver cancer	0.00289	0.00294	CcSEcCtD
Salbutamol—Constipation—Sorafenib—liver cancer	0.00289	0.00294	CcSEcCtD
Salbutamol—Pulmonary oedema—Doxorubicin—liver cancer	0.00288	0.00294	CcSEcCtD
Salbutamol—Hypertonia—Doxorubicin—liver cancer	0.00284	0.00289	CcSEcCtD
Salbutamol—Eczema—Epirubicin—liver cancer	0.00283	0.00288	CcSEcCtD
Salbutamol—Mental disability—Doxorubicin—liver cancer	0.00281	0.00286	CcSEcCtD
Salbutamol—Isoprenaline—CYP1A1—liver cancer	0.00279	0.148	CrCbGaD
Salbutamol—Gastrointestinal pain—Sorafenib—liver cancer	0.00276	0.00282	CcSEcCtD
Salbutamol—Lymphadenopathy—Doxorubicin—liver cancer	0.00275	0.00281	CcSEcCtD
Salbutamol—Increased appetite—Epirubicin—liver cancer	0.0027	0.00276	CcSEcCtD
Salbutamol—Diabetes mellitus—Doxorubicin—liver cancer	0.0027	0.00275	CcSEcCtD
Salbutamol—Urticaria—Sorafenib—liver cancer	0.00268	0.00274	CcSEcCtD
Salbutamol—Body temperature increased—Sorafenib—liver cancer	0.00267	0.00272	CcSEcCtD
Salbutamol—Abdominal pain—Sorafenib—liver cancer	0.00267	0.00272	CcSEcCtD
Salbutamol—Eczema—Doxorubicin—liver cancer	0.00262	0.00267	CcSEcCtD
Salbutamol—Hypoglycaemia—Epirubicin—liver cancer	0.0026	0.00265	CcSEcCtD
Salbutamol—Increased appetite—Doxorubicin—liver cancer	0.0025	0.00255	CcSEcCtD
Salbutamol—Migraine—Epirubicin—liver cancer	0.0025	0.00255	CcSEcCtD
Salbutamol—Affect lability—Epirubicin—liver cancer	0.0025	0.00255	CcSEcCtD
Salbutamol—Hypersensitivity—Sorafenib—liver cancer	0.00249	0.00254	CcSEcCtD
Salbutamol—Asthenia—Sorafenib—liver cancer	0.00242	0.00247	CcSEcCtD
Salbutamol—Hypoglycaemia—Doxorubicin—liver cancer	0.00241	0.00245	CcSEcCtD
Salbutamol—Mood swings—Epirubicin—liver cancer	0.00241	0.00245	CcSEcCtD
Salbutamol—Pruritus—Sorafenib—liver cancer	0.00239	0.00244	CcSEcCtD
Salbutamol—Ataxia—Epirubicin—liver cancer	0.00239	0.00243	CcSEcCtD
Salbutamol—Abdominal pain upper—Epirubicin—liver cancer	0.00232	0.00236	CcSEcCtD
Salbutamol—Migraine—Doxorubicin—liver cancer	0.00231	0.00236	CcSEcCtD
Salbutamol—Affect lability—Doxorubicin—liver cancer	0.00231	0.00236	CcSEcCtD
Salbutamol—Hypokalaemia—Epirubicin—liver cancer	0.00231	0.00236	CcSEcCtD
Salbutamol—Diarrhoea—Sorafenib—liver cancer	0.00231	0.00236	CcSEcCtD
Salbutamol—Nasopharyngitis—Epirubicin—liver cancer	0.00227	0.00231	CcSEcCtD
Salbutamol—Dizziness—Sorafenib—liver cancer	0.00223	0.00228	CcSEcCtD
Salbutamol—Mood swings—Doxorubicin—liver cancer	0.00223	0.00227	CcSEcCtD
Salbutamol—Abdominal distension—Epirubicin—liver cancer	0.00221	0.00225	CcSEcCtD
Salbutamol—Ataxia—Doxorubicin—liver cancer	0.00221	0.00225	CcSEcCtD
Salbutamol—Influenza—Epirubicin—liver cancer	0.0022	0.00224	CcSEcCtD
Salbutamol—Asthma—Epirubicin—liver cancer	0.0022	0.00224	CcSEcCtD
Salbutamol—Vomiting—Sorafenib—liver cancer	0.00215	0.00219	CcSEcCtD
Salbutamol—Abdominal pain upper—Doxorubicin—liver cancer	0.00215	0.00219	CcSEcCtD
Salbutamol—Hypokalaemia—Doxorubicin—liver cancer	0.00214	0.00218	CcSEcCtD
Salbutamol—Angina pectoris—Epirubicin—liver cancer	0.00214	0.00218	CcSEcCtD
Salbutamol—Rash—Sorafenib—liver cancer	0.00213	0.00217	CcSEcCtD
Salbutamol—Dermatitis—Sorafenib—liver cancer	0.00213	0.00217	CcSEcCtD
Salbutamol—Headache—Sorafenib—liver cancer	0.00212	0.00216	CcSEcCtD
Salbutamol—Bronchitis—Epirubicin—liver cancer	0.00211	0.00215	CcSEcCtD
Salbutamol—Nasopharyngitis—Doxorubicin—liver cancer	0.0021	0.00214	CcSEcCtD
Salbutamol—Dysuria—Epirubicin—liver cancer	0.00205	0.00209	CcSEcCtD
Salbutamol—Abdominal distension—Doxorubicin—liver cancer	0.00204	0.00208	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Epirubicin—liver cancer	0.00204	0.00208	CcSEcCtD
Salbutamol—Asthma—Doxorubicin—liver cancer	0.00203	0.00207	CcSEcCtD
Salbutamol—Influenza—Doxorubicin—liver cancer	0.00203	0.00207	CcSEcCtD
Salbutamol—Nausea—Sorafenib—liver cancer	0.00201	0.00205	CcSEcCtD
Salbutamol—Hyperglycaemia—Epirubicin—liver cancer	0.00198	0.00202	CcSEcCtD
Salbutamol—Angina pectoris—Doxorubicin—liver cancer	0.00198	0.00202	CcSEcCtD
Salbutamol—Drowsiness—Epirubicin—liver cancer	0.00196	0.002	CcSEcCtD
Salbutamol—Bronchitis—Doxorubicin—liver cancer	0.00195	0.00199	CcSEcCtD
Salbutamol—Neuropathy peripheral—Epirubicin—liver cancer	0.00192	0.00196	CcSEcCtD
Salbutamol—Stomatitis—Epirubicin—liver cancer	0.00191	0.00194	CcSEcCtD
Salbutamol—Jaundice—Epirubicin—liver cancer	0.00191	0.00194	CcSEcCtD
Salbutamol—Conjunctivitis—Epirubicin—liver cancer	0.0019	0.00194	CcSEcCtD
Salbutamol—Urinary tract infection—Epirubicin—liver cancer	0.0019	0.00194	CcSEcCtD
Salbutamol—Dysuria—Doxorubicin—liver cancer	0.0019	0.00194	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00189	0.00192	CcSEcCtD
Salbutamol—Sweating—Epirubicin—liver cancer	0.00188	0.00191	CcSEcCtD
Salbutamol—Haematuria—Epirubicin—liver cancer	0.00187	0.0019	CcSEcCtD
Salbutamol—Epistaxis—Epirubicin—liver cancer	0.00185	0.00188	CcSEcCtD
Salbutamol—Sinusitis—Epirubicin—liver cancer	0.00184	0.00187	CcSEcCtD
Salbutamol—Hyperglycaemia—Doxorubicin—liver cancer	0.00183	0.00187	CcSEcCtD
Salbutamol—Drowsiness—Doxorubicin—liver cancer	0.00181	0.00185	CcSEcCtD
Salbutamol—Neuropathy peripheral—Doxorubicin—liver cancer	0.00178	0.00181	CcSEcCtD
Salbutamol—Haemoglobin—Epirubicin—liver cancer	0.00177	0.0018	CcSEcCtD
Salbutamol—Jaundice—Doxorubicin—liver cancer	0.00177	0.0018	CcSEcCtD
Salbutamol—Stomatitis—Doxorubicin—liver cancer	0.00177	0.0018	CcSEcCtD
Salbutamol—Rhinitis—Epirubicin—liver cancer	0.00176	0.0018	CcSEcCtD
Salbutamol—Urinary tract infection—Doxorubicin—liver cancer	0.00176	0.00179	CcSEcCtD
Salbutamol—Conjunctivitis—Doxorubicin—liver cancer	0.00176	0.00179	CcSEcCtD
Salbutamol—Haemorrhage—Epirubicin—liver cancer	0.00176	0.00179	CcSEcCtD
Salbutamol—Hypoaesthesia—Epirubicin—liver cancer	0.00175	0.00178	CcSEcCtD
Salbutamol—Pharyngitis—Epirubicin—liver cancer	0.00174	0.00178	CcSEcCtD
Salbutamol—Sweating—Doxorubicin—liver cancer	0.00174	0.00177	CcSEcCtD
Salbutamol—Urinary tract disorder—Epirubicin—liver cancer	0.00174	0.00177	CcSEcCtD
Salbutamol—Haematuria—Doxorubicin—liver cancer	0.00173	0.00176	CcSEcCtD
Salbutamol—Connective tissue disorder—Epirubicin—liver cancer	0.00173	0.00176	CcSEcCtD
Salbutamol—Urethral disorder—Epirubicin—liver cancer	0.00172	0.00176	CcSEcCtD
Salbutamol—Epistaxis—Doxorubicin—liver cancer	0.00171	0.00174	CcSEcCtD
Salbutamol—Sinusitis—Doxorubicin—liver cancer	0.0017	0.00173	CcSEcCtD
Salbutamol—Tinnitus—Epirubicin—liver cancer	0.00164	0.00167	CcSEcCtD
Salbutamol—Haemoglobin—Doxorubicin—liver cancer	0.00163	0.00167	CcSEcCtD
Salbutamol—Cardiac disorder—Epirubicin—liver cancer	0.00163	0.00166	CcSEcCtD
Salbutamol—Flushing—Epirubicin—liver cancer	0.00163	0.00166	CcSEcCtD
Salbutamol—Rhinitis—Doxorubicin—liver cancer	0.00163	0.00166	CcSEcCtD
Salbutamol—Haemorrhage—Doxorubicin—liver cancer	0.00163	0.00166	CcSEcCtD
Salbutamol—Hypoaesthesia—Doxorubicin—liver cancer	0.00162	0.00165	CcSEcCtD
Salbutamol—Pharyngitis—Doxorubicin—liver cancer	0.00161	0.00164	CcSEcCtD
Salbutamol—Urinary tract disorder—Doxorubicin—liver cancer	0.00161	0.00164	CcSEcCtD
Salbutamol—Connective tissue disorder—Doxorubicin—liver cancer	0.0016	0.00163	CcSEcCtD
Salbutamol—Angiopathy—Epirubicin—liver cancer	0.00159	0.00162	CcSEcCtD
Salbutamol—Urethral disorder—Doxorubicin—liver cancer	0.00159	0.00162	CcSEcCtD
Salbutamol—Immune system disorder—Epirubicin—liver cancer	0.00159	0.00162	CcSEcCtD
Salbutamol—Mediastinal disorder—Epirubicin—liver cancer	0.00158	0.00161	CcSEcCtD
Salbutamol—Chills—Epirubicin—liver cancer	0.00158	0.00161	CcSEcCtD
Salbutamol—Arrhythmia—Epirubicin—liver cancer	0.00157	0.0016	CcSEcCtD
Salbutamol—Mental disorder—Epirubicin—liver cancer	0.00154	0.00157	CcSEcCtD
Salbutamol—Malnutrition—Epirubicin—liver cancer	0.00153	0.00156	CcSEcCtD
Salbutamol—Tinnitus—Doxorubicin—liver cancer	0.00152	0.00155	CcSEcCtD
Salbutamol—Cardiac disorder—Doxorubicin—liver cancer	0.00151	0.00154	CcSEcCtD
Salbutamol—Flushing—Doxorubicin—liver cancer	0.00151	0.00154	CcSEcCtD
Salbutamol—Flatulence—Epirubicin—liver cancer	0.00151	0.00154	CcSEcCtD
Salbutamol—Tension—Epirubicin—liver cancer	0.0015	0.00153	CcSEcCtD
Salbutamol—Dysgeusia—Epirubicin—liver cancer	0.0015	0.00153	CcSEcCtD
Salbutamol—Nervousness—Epirubicin—liver cancer	0.00149	0.00151	CcSEcCtD
Salbutamol—Back pain—Epirubicin—liver cancer	0.00148	0.00151	CcSEcCtD
Salbutamol—Angiopathy—Doxorubicin—liver cancer	0.00148	0.0015	CcSEcCtD
Salbutamol—Muscle spasms—Epirubicin—liver cancer	0.00147	0.0015	CcSEcCtD
Salbutamol—Immune system disorder—Doxorubicin—liver cancer	0.00147	0.0015	CcSEcCtD
Salbutamol—Mediastinal disorder—Doxorubicin—liver cancer	0.00147	0.00149	CcSEcCtD
Salbutamol—Chills—Doxorubicin—liver cancer	0.00146	0.00149	CcSEcCtD
Salbutamol—Arrhythmia—Doxorubicin—liver cancer	0.00145	0.00148	CcSEcCtD
Salbutamol—Mental disorder—Doxorubicin—liver cancer	0.00142	0.00145	CcSEcCtD
Salbutamol—Ill-defined disorder—Epirubicin—liver cancer	0.00142	0.00145	CcSEcCtD
Salbutamol—Malnutrition—Doxorubicin—liver cancer	0.00142	0.00144	CcSEcCtD
Salbutamol—Agitation—Epirubicin—liver cancer	0.00141	0.00143	CcSEcCtD
Salbutamol—Flatulence—Doxorubicin—liver cancer	0.00139	0.00142	CcSEcCtD
Salbutamol—Tension—Doxorubicin—liver cancer	0.00139	0.00142	CcSEcCtD
Salbutamol—Dysgeusia—Doxorubicin—liver cancer	0.00139	0.00141	CcSEcCtD
Salbutamol—Malaise—Epirubicin—liver cancer	0.00138	0.00141	CcSEcCtD
Salbutamol—Nervousness—Doxorubicin—liver cancer	0.00137	0.0014	CcSEcCtD
Salbutamol—Vertigo—Epirubicin—liver cancer	0.00137	0.0014	CcSEcCtD
Salbutamol—Syncope—Epirubicin—liver cancer	0.00137	0.0014	CcSEcCtD
Salbutamol—Back pain—Doxorubicin—liver cancer	0.00137	0.0014	CcSEcCtD
Salbutamol—Muscle spasms—Doxorubicin—liver cancer	0.00136	0.00139	CcSEcCtD
Salbutamol—Palpitations—Epirubicin—liver cancer	0.00135	0.00138	CcSEcCtD
Salbutamol—Loss of consciousness—Epirubicin—liver cancer	0.00134	0.00137	CcSEcCtD
Salbutamol—Cough—Epirubicin—liver cancer	0.00133	0.00136	CcSEcCtD
Salbutamol—Hypertension—Epirubicin—liver cancer	0.00132	0.00135	CcSEcCtD
Salbutamol—Ill-defined disorder—Doxorubicin—liver cancer	0.00131	0.00134	CcSEcCtD
Salbutamol—Myalgia—Epirubicin—liver cancer	0.0013	0.00133	CcSEcCtD
Salbutamol—Chest pain—Epirubicin—liver cancer	0.0013	0.00133	CcSEcCtD
Salbutamol—Arthralgia—Epirubicin—liver cancer	0.0013	0.00133	CcSEcCtD
Salbutamol—Agitation—Doxorubicin—liver cancer	0.0013	0.00133	CcSEcCtD
Salbutamol—Anxiety—Epirubicin—liver cancer	0.0013	0.00132	CcSEcCtD
Salbutamol—Discomfort—Epirubicin—liver cancer	0.00129	0.00131	CcSEcCtD
Salbutamol—Malaise—Doxorubicin—liver cancer	0.00128	0.0013	CcSEcCtD
Salbutamol—Dry mouth—Epirubicin—liver cancer	0.00127	0.0013	CcSEcCtD
Salbutamol—Vertigo—Doxorubicin—liver cancer	0.00127	0.0013	CcSEcCtD
Salbutamol—Syncope—Doxorubicin—liver cancer	0.00127	0.00129	CcSEcCtD
Salbutamol—Palpitations—Doxorubicin—liver cancer	0.00125	0.00127	CcSEcCtD
Salbutamol—Oedema—Epirubicin—liver cancer	0.00125	0.00127	CcSEcCtD
Salbutamol—Anaphylactic shock—Epirubicin—liver cancer	0.00125	0.00127	CcSEcCtD
Salbutamol—Loss of consciousness—Doxorubicin—liver cancer	0.00124	0.00127	CcSEcCtD
Salbutamol—Infection—Epirubicin—liver cancer	0.00124	0.00126	CcSEcCtD
Salbutamol—Cough—Doxorubicin—liver cancer	0.00124	0.00126	CcSEcCtD
Salbutamol—Shock—Epirubicin—liver cancer	0.00123	0.00125	CcSEcCtD
Salbutamol—Nervous system disorder—Epirubicin—liver cancer	0.00122	0.00125	CcSEcCtD
Salbutamol—Hypertension—Doxorubicin—liver cancer	0.00122	0.00125	CcSEcCtD
Salbutamol—Tachycardia—Epirubicin—liver cancer	0.00122	0.00124	CcSEcCtD
Salbutamol—Skin disorder—Epirubicin—liver cancer	0.00121	0.00124	CcSEcCtD
Salbutamol—Hyperhidrosis—Epirubicin—liver cancer	0.00121	0.00123	CcSEcCtD
Salbutamol—Arthralgia—Doxorubicin—liver cancer	0.0012	0.00123	CcSEcCtD
Salbutamol—Chest pain—Doxorubicin—liver cancer	0.0012	0.00123	CcSEcCtD
Salbutamol—Myalgia—Doxorubicin—liver cancer	0.0012	0.00123	CcSEcCtD
Salbutamol—Anxiety—Doxorubicin—liver cancer	0.0012	0.00122	CcSEcCtD
Salbutamol—Discomfort—Doxorubicin—liver cancer	0.00119	0.00121	CcSEcCtD
Salbutamol—Anorexia—Epirubicin—liver cancer	0.00119	0.00121	CcSEcCtD
Salbutamol—Dry mouth—Doxorubicin—liver cancer	0.00118	0.0012	CcSEcCtD
Salbutamol—Hypotension—Epirubicin—liver cancer	0.00117	0.00119	CcSEcCtD
Salbutamol—Oedema—Doxorubicin—liver cancer	0.00116	0.00118	CcSEcCtD
Salbutamol—Anaphylactic shock—Doxorubicin—liver cancer	0.00116	0.00118	CcSEcCtD
Salbutamol—Infection—Doxorubicin—liver cancer	0.00115	0.00117	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00114	0.00116	CcSEcCtD
Salbutamol—Shock—Doxorubicin—liver cancer	0.00114	0.00116	CcSEcCtD
Salbutamol—Nervous system disorder—Doxorubicin—liver cancer	0.00113	0.00115	CcSEcCtD
Salbutamol—Insomnia—Epirubicin—liver cancer	0.00113	0.00115	CcSEcCtD
Salbutamol—Tachycardia—Doxorubicin—liver cancer	0.00113	0.00115	CcSEcCtD
Salbutamol—Skin disorder—Doxorubicin—liver cancer	0.00112	0.00114	CcSEcCtD
Salbutamol—Paraesthesia—Epirubicin—liver cancer	0.00112	0.00114	CcSEcCtD
Salbutamol—Hyperhidrosis—Doxorubicin—liver cancer	0.00112	0.00114	CcSEcCtD
Salbutamol—Dyspnoea—Epirubicin—liver cancer	0.00111	0.00113	CcSEcCtD
Salbutamol—Somnolence—Epirubicin—liver cancer	0.00111	0.00113	CcSEcCtD
Salbutamol—Anorexia—Doxorubicin—liver cancer	0.0011	0.00112	CcSEcCtD
Salbutamol—Dyspepsia—Epirubicin—liver cancer	0.0011	0.00112	CcSEcCtD
Salbutamol—Decreased appetite—Epirubicin—liver cancer	0.00109	0.00111	CcSEcCtD
Salbutamol—Hypotension—Doxorubicin—liver cancer	0.00108	0.0011	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Epirubicin—liver cancer	0.00108	0.0011	CcSEcCtD
Salbutamol—Fatigue—Epirubicin—liver cancer	0.00108	0.0011	CcSEcCtD
Salbutamol—Pain—Epirubicin—liver cancer	0.00107	0.00109	CcSEcCtD
Salbutamol—Constipation—Epirubicin—liver cancer	0.00107	0.00109	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00105	0.00107	CcSEcCtD
Salbutamol—Insomnia—Doxorubicin—liver cancer	0.00104	0.00106	CcSEcCtD
Salbutamol—Paraesthesia—Doxorubicin—liver cancer	0.00104	0.00106	CcSEcCtD
Salbutamol—Dyspnoea—Doxorubicin—liver cancer	0.00103	0.00105	CcSEcCtD
Salbutamol—Feeling abnormal—Epirubicin—liver cancer	0.00103	0.00105	CcSEcCtD
Salbutamol—Somnolence—Doxorubicin—liver cancer	0.00103	0.00105	CcSEcCtD
Salbutamol—Gastrointestinal pain—Epirubicin—liver cancer	0.00102	0.00104	CcSEcCtD
Salbutamol—Dyspepsia—Doxorubicin—liver cancer	0.00102	0.00104	CcSEcCtD
Salbutamol—Decreased appetite—Doxorubicin—liver cancer	0.001	0.00102	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000997	0.00102	CcSEcCtD
Salbutamol—Fatigue—Doxorubicin—liver cancer	0.000996	0.00102	CcSEcCtD
Salbutamol—Urticaria—Epirubicin—liver cancer	0.000992	0.00101	CcSEcCtD
Salbutamol—Pain—Doxorubicin—liver cancer	0.000988	0.00101	CcSEcCtD
Salbutamol—Constipation—Doxorubicin—liver cancer	0.000988	0.00101	CcSEcCtD
Salbutamol—Body temperature increased—Epirubicin—liver cancer	0.000987	0.00101	CcSEcCtD
Salbutamol—Abdominal pain—Epirubicin—liver cancer	0.000987	0.00101	CcSEcCtD
Salbutamol—Feeling abnormal—Doxorubicin—liver cancer	0.000952	0.00097	CcSEcCtD
Salbutamol—Gastrointestinal pain—Doxorubicin—liver cancer	0.000945	0.000963	CcSEcCtD
Salbutamol—Hypersensitivity—Epirubicin—liver cancer	0.00092	0.000937	CcSEcCtD
Salbutamol—Urticaria—Doxorubicin—liver cancer	0.000918	0.000935	CcSEcCtD
Salbutamol—Abdominal pain—Doxorubicin—liver cancer	0.000913	0.000931	CcSEcCtD
Salbutamol—Body temperature increased—Doxorubicin—liver cancer	0.000913	0.000931	CcSEcCtD
Salbutamol—Asthenia—Epirubicin—liver cancer	0.000896	0.000913	CcSEcCtD
Salbutamol—Pruritus—Epirubicin—liver cancer	0.000883	0.0009	CcSEcCtD
Salbutamol—Diarrhoea—Epirubicin—liver cancer	0.000854	0.000871	CcSEcCtD
Salbutamol—Hypersensitivity—Doxorubicin—liver cancer	0.000851	0.000867	CcSEcCtD
Salbutamol—Asthenia—Doxorubicin—liver cancer	0.000829	0.000845	CcSEcCtD
Salbutamol—Dizziness—Epirubicin—liver cancer	0.000826	0.000841	CcSEcCtD
Salbutamol—Pruritus—Doxorubicin—liver cancer	0.000817	0.000833	CcSEcCtD
Salbutamol—Vomiting—Epirubicin—liver cancer	0.000794	0.000809	CcSEcCtD
Salbutamol—Diarrhoea—Doxorubicin—liver cancer	0.00079	0.000806	CcSEcCtD
Salbutamol—Rash—Epirubicin—liver cancer	0.000787	0.000802	CcSEcCtD
Salbutamol—Dermatitis—Epirubicin—liver cancer	0.000786	0.000802	CcSEcCtD
Salbutamol—Headache—Epirubicin—liver cancer	0.000782	0.000797	CcSEcCtD
Salbutamol—Dizziness—Doxorubicin—liver cancer	0.000764	0.000779	CcSEcCtD
Salbutamol—Nausea—Epirubicin—liver cancer	0.000742	0.000756	CcSEcCtD
Salbutamol—Vomiting—Doxorubicin—liver cancer	0.000734	0.000749	CcSEcCtD
Salbutamol—Rash—Doxorubicin—liver cancer	0.000728	0.000742	CcSEcCtD
Salbutamol—Dermatitis—Doxorubicin—liver cancer	0.000728	0.000742	CcSEcCtD
Salbutamol—Headache—Doxorubicin—liver cancer	0.000724	0.000738	CcSEcCtD
Salbutamol—Nausea—Doxorubicin—liver cancer	0.000686	0.000699	CcSEcCtD
